£60.00

VDM Verlag Prognostic and Predictive Markers for Hepatocellular Cancer: Review of markers assisting in treatment decision for Hepatocellular Carcinoma

Price data last checked 23 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£60 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical
Generating forecast…
£60.00 £57.00 £58.20 £59.40 £60.60 £61.80 £63.00 09 July 2026 25 July 2026 11 August 2026 28 August 2026 14 September 2026

Price Distribution

Price distribution over 68 days • 1 price levels

Days at Price
68 days 0 17 34 51 68 £60 Days at Price

Price Analysis

Most common price: £60 (68 days, 100.0%)

Price range: £60 - £60

Price levels: 1 different prices over 68 days

Description

HCC is one of the most common malignancies worldwide. The outcome for patients with HCC still dismal, although it has improved much in the past few decades, a definitive subset is cured by surgery only, and encouraging long-term survival of patients have been obtained in some clinical centers. The life expectancy of HCC patients is hard to predict, making it difficult to decide the patient's prognosis. Alfa- Feto protein (AFP) remains the most commonly & accepted prognostic biomarker used in the management of HCC but with no positive impact on the course of the disease. That necessitated the studying of new molecular biomarkers and their role in early detection and prediction of the clinical course of the disease. A large number of molecular biological factors have been shown to associate with the invasiveness of HCC, and have potential prognostic significance. However, these markers are not routinely available for the prediction of HCC prognosis. This book we will try to validate data about the new advances in the prognostic and predictive markers for HCC, verifying a simple prognostic model for patients with untreated HCC for use in developing countries.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
18 August 2011
Listed Since
24 August 2011

Barcode

No barcode data available

Similar Products You Might Like

Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)
87% match

Precision Molecular Pathology of Liver Cancer (Molecular Pathology Library)

Springer

£71.94 08 Aug 2026
An Information Technology Framework for Predictive, Preventive and Personalised Medicine: A Use-Case with Hepatocellular Carcinoma: 8 (Advances in Predictive, Preventive and Personalised Medicine, 8)
83% match

An Information Technology Framework for Predictive, Preventive and Personalised Medicine: A Use-Case with Hepatocellular Carcinoma: 8 (Advances in Predictive, Preventive and Personalised Medicine, 8)

Springer

£76.42 07 Aug 2026
Hilar Cholangiocarcinoma
82% match

Hilar Cholangiocarcinoma

Springer

£81.74 06 Aug 2026
81% match

Precision Oncology in Liver Cancer: Genomics, Infection, and the Exposome in African and Global Contexts

Elsevier

£145.99 06 Aug 2026
Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)
81% match

Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£129.99 06 Aug 2026
Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)
81% match

Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)

Springer

£74.67 29 Aug 2026
Liver Metastases
81% match

Liver Metastases

Springer

£80.67 08 Aug 2026
New Advances on Disease Biomarkers and Molecular Targets in Biomedicine
80% match

New Advances on Disease Biomarkers and Molecular Targets in Biomedicine

Humana

£88.21 19 Aug 2026
Management of Pancreatic Cancer and Cholangiocarcinoma
80% match

Management of Pancreatic Cancer and Cholangiocarcinoma

Springer

£103.27 18 Aug 2026
Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma
80% match

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

Springer

£78.01 04 Aug 2026
Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms
80% match

Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms

Springer

£89.28 13 Sep 2026
Prognostic variables in node-negative and node-positive breast cancer
79% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£153.04 05 Aug 2026
Hepatobiliary Surgery (Vademecum)
79% match

Hepatobiliary Surgery (Vademecum)

CRC Press

£50.34 07 Aug 2026
Therapeutic Strategies in Primary and Metastatic Liver Cancer: 100 (Recent Results in Cancer Research, 100)
79% match

Therapeutic Strategies in Primary and Metastatic Liver Cancer: 100 (Recent Results in Cancer Research, 100)

Springer

£76.42 15 Sep 2026
Surgical Pathology of Liver Tumors
79% match

Surgical Pathology of Liver Tumors

Springer

£74.21 13 Aug 2026
Cancer Biomarkers
79% match

Cancer Biomarkers

£64.99 15 Sep 2026
Signaling Pathways in Liver Diseases
79% match

Signaling Pathways in Liver Diseases

Springer

£154.53 29 Aug 2026
The Effect of Laser Induced Thermal Ablation on Liver Tumours
79% match

The Effect of Laser Induced Thermal Ablation on Liver Tumours

VDM Verlag

£65.56 15 Sep 2026
Tumor Biomarker Discovery: Methods and Protocols: 520 (Methods in Molecular Biology, 520)
79% match

Tumor Biomarker Discovery: Methods and Protocols: 520 (Methods in Molecular Biology, 520)

Humana

£82.35 12 Sep 2026
Practical Oncologic Molecular Pathology: Frequently Asked Questions (Practical Anatomic Pathology)
79% match

Practical Oncologic Molecular Pathology: Frequently Asked Questions (Practical Anatomic Pathology)

Springer

£80.11 04 Aug 2026
Hepatobiliary and Pancreatic Carcinogenesis in the Hamster
79% match

Hepatobiliary and Pancreatic Carcinogenesis in the Hamster

Springer

£108.01 31 Jul 2026
Molecular Pathology and Diagnostics of Cancer: 16 (Cancer Growth and Progression, 16)
79% match

Molecular Pathology and Diagnostics of Cancer: 16 (Cancer Growth and Progression, 16)

Springer

£108.75 31 Aug 2026
Risk factors of Hepatocellular carcinoma
78% match

Risk factors of Hepatocellular carcinoma

LAP Lambert Academic Publishing

£54.00 25 Aug 2026
Noncolorectal, Nonneuroendocrine Liver Metastases: Diagnosis and Current Therapies
78% match

Noncolorectal, Nonneuroendocrine Liver Metastases: Diagnosis and Current Therapies

Springer

£88.21 10 Aug 2026